AstraZeneca PLC/ GB0009895292 /
2024-10-01 12:00:00 AM | Chg. +34.00 | Volume | Bid5:29:43 PM | Ask5:29:43 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,605.50SEK | +2.16% | 243,710 Turnover: 378.3 mill. |
1,607.00Bid Size: - | 1,608.00Ask Size: - | 2520.69 bill.SEK | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 3.84 USD | 81.13% |
EPS Diluted: | - USD | 80.57% |
Revenues per Share: | 29.55 USD | 3.28% |
Book Value per Share: | 25.25 USD | 5.68% |
Cash Flow per Share: | 6.67 USD | 5.46% |
Dividend per Share: | 2.90 USD | 0.00% |
Total | in mill. | |
Revenues: | 45,811.00 USD | 3.29% |
Net Income: | 5,955.00 USD | 84.48% |
Operating Cash Flow: | 10,345.00 USD | - |
Cash and Cash Equivalents: | 5,840.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 41.25 | 35.16 |
P/S Ratio: | 5.36 | 4.57 |
P/BV ratio: | 6.27 | 5.35 |
P/CF Ratio: | 23.73 | 20.23 |
PEG: | 0.51 | 0.43 |
Earnings Yield: | 2.42% | 2.84% |
Dividend Yield: | 1.83% | 2.15% |
Market Capitalization | ||
Market Capitalization: | 2520.69 bill. SEK | 2110.49 bill. SEK |
Free Float Market Cap.: | - SEK | - SEK |
Market Cap. / Employee: | 28.04 mill. SEK | 23.48 mill. SEK |
Shares Outstanding: | 1.55 bill. |
Profitability
Gross Profit Margin: | 81.95% |
EBIT Margin: | 17.88% |
Net Profit Margin: | 13.00% |
Return on Equity: | 15.21% |
Return on Assets: | 5.89% |
Financial Strength
Liquidity I / Cash Ratio: | 19.12% |
Liquidity II / Quick Ratio: | 58.82% |
Liquidity III / Current Ratio: | 82.03% |
Debt / Equity Ratio: | 158.33% |
Dynam. Debt / Equity Ratio: | 599.09% |
Efficiency
Employees: | 89,900 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 509,577.31 USD |
Net Income / Employee: | 66,240.27 USD |
Total Assets / Employee: | 1,124,794.22 USD |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | USD |